Amyotrophic Lateral Sclerosis (ALS) remains a devastating neurodegenerative disease characterized by the progressive loss of upper and lower motor neurons. The ALS treatment landscape is evolving from disease-slowing symptomatic management toward targeted neuroprotective drugs, antisense oligonucleotides (ASOs), gene therapies, and ...Read more
Home/amyotrophic lateral sclerosis market size
